Volume 123, Issue 2, Pages 483-491 (August 2002) Interferon therapy prolonged life expectancy among chronic hepatitis C patients Haruhiko Yoshida, Yasuyuki Arakawa, Michio Sata, Shuhei Nishiguchi, Michitami Yano, Shigetoshi Fujiyama, Gotarou Yamada, Osamu Yokosuka, Yasushi Shiratori, Masao Omata Gastroenterology Volume 123, Issue 2, Pages 483-491 (August 2002) DOI: 10.1053/gast.2002.34785 Copyright © 2002 American Gastroenterological Association Terms and Conditions
Fig. 1 Cumulative survival (A) among untreated chronic hepatitis C patients (30 deaths among 459 patients), (B) among interferon-treated chronic hepatitis C patients (56 deaths among 2430 patients), (C) among virologic sustained responders to interferon (7 deaths among 817 patients), and (D) among nonsustained responders (49 deaths among 1613 patients). Survival curves were determined by the Kaplan-Meier method. Dotted lines indicate the upper and lower 95% confidence limits. Circles represent the expected survival probability based on the mortality in gender- and age-matched general population in Japan. Gastroenterology 2002 123, 483-491DOI: (10.1053/gast.2002.34785) Copyright © 2002 American Gastroenterological Association Terms and Conditions